On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

After the success of a public service advertisement campaign aimed at improving recognition of the early signs of Alzheimer’s disease ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Ahead of a planned trial next month, Jazz Pharmaceuticals is moving to resolve antitrust allegations surrounding its key ...

Ask a healthcare professional (HCP) to name a psychiatric medicine and chances are they’ll say a brand approved at least 10 ...

Over the last few years, with fears increased in the healthcare industry that its top executives could be targets of violence ...

Looking to cement its spot in the burgeoning realm of radiopharmaceuticals, Florida-based contract manufacturer PharmaLogic ...

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

Mucinex maker Reckitt Beckiser’s new “simpler and more effective organization” won’t include 190 New Jersey workers. | ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a ...

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain ...